A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

NCT01288079 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: TC-5214
DRUG: Duloxetine
DRUG: Placebo

Sponsor

AstraZeneca